These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3130680)

  • 1. Platelets and the puzzles of pulmonary pyrrolizidine poisoning.
    Roth RA; Ganey PE
    Toxicol Appl Pharmacol; 1988 May; 93(3):463-71. PubMed ID: 3130680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
    Ganey PE; Roth RA
    Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
    Roth RA; Reindel JF
    Adv Exp Med Biol; 1991; 283():477-87. PubMed ID: 1906225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
    White SM; Wagner JG; Roth RA
    Toxicol Appl Pharmacol; 1989 Jun; 99(2):302-13. PubMed ID: 2734793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE; Sprugel KH; Hadley KB; Roth RA
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
    Ganey PE; Sprugel KH; White SM; Wagner JG; Roth RA
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1165-72. PubMed ID: 3189578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity.
    Bruner LH; Carpenter LJ; Hamlow P; Roth RA
    Toxicol Appl Pharmacol; 1986 Sep; 85(3):416-27. PubMed ID: 3094196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
    Ganey PE; Roth RA
    Am J Physiol; 1987 Apr; 252(4 Pt 2):H743-8. PubMed ID: 2952022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
    Hilliker KS; Bell TG; Lorimer D; Roth RA
    Am J Physiol; 1984 Jun; 246(6 Pt 2):H747-53. PubMed ID: 6742140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Ketoprostaglandin F1 alpha and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline pyrrole-treated rats.
    Ganey PE; Roth RA
    J Toxicol Environ Health; 1988; 23(1):127-37. PubMed ID: 3336057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats.
    White SM; Roth RA
    Toxicol Appl Pharmacol; 1988 Dec; 96(3):465-75. PubMed ID: 2974653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
    Hilliker KS; Bell TG; Roth RA
    Thromb Haemost; 1983 Dec; 50(4):844-7. PubMed ID: 6665765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid metabolites and the mechanisms of monocrotaline pneumotoxicity.
    Roth RA; Ganey PE
    Am Rev Respir Dis; 1987 Sep; 136(3):762-5. PubMed ID: 2820283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Schultze AE; Wagner JG; Roth RA
    Toxicol Appl Pharmacol; 1991 Jul; 109(3):421-31. PubMed ID: 1830177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats.
    Ganey PE; Roth RA
    Exp Lung Res; 1987; 12(3):195-206. PubMed ID: 3107969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
    Bruner LH; Bull RW; Roth RA
    Toxicol Appl Pharmacol; 1987 Oct; 91(1):1-12. PubMed ID: 3672514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices.
    Hilliker KS; Garcia CM; Roth RA
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):179-97. PubMed ID: 6410470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early indications of monocrotaline pyrrole-induced lung injury in rats.
    Schultze AE; Wagner JG; White SM; Roth RA
    Toxicol Appl Pharmacol; 1991 Jun; 109(1):41-50. PubMed ID: 2038748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC; Wilson DW; Lamé MW; Jones AD; Segall HJ
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):87-97. PubMed ID: 8430429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
    Hilliker KS; Roth RA
    Am Rev Respir Dis; 1985 Jan; 131(1):46-50. PubMed ID: 3966714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.